This dual-immunotherapy neoadjuvant treatment regimen is mainly intended for patients with resectable stage IIB to III colon ...

China NMPA grants marketing approval for Innovent Biologics' Tyvyt, a CTLA-4 monoclonal antibody: San Francisco Saturday, December 27, 2025, 16:00 Hrs [IST] Innovent Biologics Inc ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack ...

Innovent Biologics has received China’s NMPA approval for the NDA for Tabosun, a CTLA-4 monoclonal antibody for colon cancer.

Innovent Biologics ( ($HK:1801) ) has provided an update. Innovent Biologics announced that China’s National Medical Products Administration has ...

We describe an unusual case of a woman in her 30s who had recently undergone Roux-en-Y gastric bypass and presented to the emergency department with a 6-week history of intractable nausea and vomiting ...

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

Claims that a Chinese man underwent surgery so that his severed hand could be grafted onto his leg in order to preserve the ...

Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its precise prevalence, transfusion practices and impact on outcomes in ...

The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major ...

The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...